The University of California San Francisco recently hosted the 8th International Breast Densitometry and Breast Cancer Risk Assessment Workshop (June 7 – 9).
Increased breast density is a key driver of breast cancer risk from long-term hormone replacement therapy use
Volpara CEO Ralph Highnam discusses the 2017 Full Year Financial Results and gives a sales update.
Volpara takes an aggressive stance on information security, partnering with Microsoft Azure to offer continuous security-health monitoring.
Despite breast density being recently declared by US researchers to be the most common risk factor to determine a woman’s chances of developing breast cancer during her lifetime, very few...
You may think a degree in math or physics is reserved for more bookish types that aim for career paths in labs, academia, or sci-fi-esque pursuits.
Every year, all 8,700 mammography clinics in the United States are inspected by the Food and Drug Administration (FDA).
Higher Volpara density leads to higher cancer rate and lower screening sensitivity of mammography.
The annual conference of the Radiological Society of North America (RSNA) has recently concluded in Chicago (November 27-December 2), with Volpara featuring in three talks and one poster presentation.